Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Signet Ring Adenocarcinoma of the Rectum”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Large-scale testing (Phase 3)Study completedNCT00005036
What this trial is testing

Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
National Cancer Institute (NCI) 560
Early research (Phase 1)Ended earlyNCT01285102
What this trial is testing

Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
Fox Chase Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT01652196
What this trial is testing

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
John Hays 56
Testing effectiveness (Phase 2)WithdrawnNCT02235324
What this trial is testing

Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+7 more
University of Southern California
Early research (Phase 1)Study completedNCT00003799
What this trial is testing

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer

Who this might be right for
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 20
Very early researchWithdrawnNCT01403103
What this trial is testing

Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Testing effectiveness (Phase 2)Ended earlyNCT01871571
What this trial is testing

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the RectumStage IIA Rectal Cancer+5 more
University of Southern California 17
Not applicableEnded earlyNCT01934179
What this trial is testing

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+9 more
Fox Chase Cancer Center 6
Early research (Phase 1)Study completedNCT02232152
What this trial is testing

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Study completedNCT00100841
What this trial is testing

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Who this might be right for
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the ColonRecurrent Colon Cancer+4 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT01726296
What this trial is testing

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Who this might be right for
Adenocarcinoma of the LungMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+23 more
Fox Chase Cancer Center 1,440
Early research (Phase 1)Ended earlyNCT01198535
What this trial is testing

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+7 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01079780
What this trial is testing

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 136
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Very early researchEnded earlyNCT00835679
What this trial is testing

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT01923337
What this trial is testing

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
University of California, Davis 17
Testing effectiveness (Phase 2)Ended earlyNCT00745134
What this trial is testing

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+6 more
M.D. Anderson Cancer Center 22
Early research (Phase 1)Ended earlyNCT02110953
What this trial is testing

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+8 more
Fox Chase Cancer Center 2
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Next Page